70 related articles for article (PubMed ID: 21130530)
1. Role of tau kinases (CDK5R1 and GSK3B) in Parkinson's disease: a study from India.
Das G; Misra AK; Das SK; Ray K; Ray J
Neurobiol Aging; 2012 Jul; 33(7):1485.e9-15. PubMed ID: 21130530
[TBL] [Abstract][Full Text] [Related]
2. GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.
Kwok JB; Hallupp M; Loy CT; Chan DK; Woo J; Mellick GD; Buchanan DD; Silburn PA; Halliday GM; Schofield PR
Ann Neurol; 2005 Dec; 58(6):829-39. PubMed ID: 16315267
[TBL] [Abstract][Full Text] [Related]
3. Epistasis between tau phosphorylation regulating genes (CDK5R1 and GSK-3beta) and Alzheimer's disease risk.
Mateo I; Vázquez-Higuera JL; Sánchez-Juan P; Rodríguez-Rodríguez E; Infante J; García-Gorostiaga I; Berciano J; Combarros O
Acta Neurol Scand; 2009 Aug; 120(2):130-3. PubMed ID: 19154537
[TBL] [Abstract][Full Text] [Related]
4. MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China.
Yu L; Huang J; Zhai D; Liu L; Guo K; Long X; Xiong J; Zhang Z; Wang Y; Zhao Y; Wu P; Wang D; Lin Z; Wu J; Xiong N; Wang T
BMC Neurosci; 2014 Apr; 15():54. PubMed ID: 24779391
[TBL] [Abstract][Full Text] [Related]
5. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.
Wider C; Vilariño-Güell C; Heckman MG; Jasinska-Myga B; Ortolaza-Soto AI; Diehl NN; Crook JE; Cobb SA; Bacon JA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
Eur J Neurol; 2011 Jun; 18(6):876-81. PubMed ID: 21159074
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A
J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549
[TBL] [Abstract][Full Text] [Related]
7. GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort.
Kalinderi K; Fidani L; Katsarou Z; Clarimón J; Bostantjopoulou S; Kotsis A
Neurobiol Aging; 2011 Mar; 32(3):546.e1-5. PubMed ID: 19573950
[TBL] [Abstract][Full Text] [Related]
8. Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians.
Das G; Misra AK; Das SK; Ray K; Ray J
Neurosci Lett; 2009 Aug; 460(1):16-20. PubMed ID: 19450659
[TBL] [Abstract][Full Text] [Related]
9. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.
Goris A; Williams-Gray CH; Clark GR; Foltynie T; Lewis SJ; Brown J; Ban M; Spillantini MG; Compston A; Burn DJ; Chinnery PF; Barker RA; Sawcer SJ
Ann Neurol; 2007 Aug; 62(2):145-53. PubMed ID: 17683088
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.
Kwok JB; Loy CT; Hamilton G; Lau E; Hallupp M; Williams J; Owen MJ; Broe GA; Tang N; Lam L; Powell JF; Lovestone S; Schofield PR
Ann Neurol; 2008 Oct; 64(4):446-54. PubMed ID: 18991351
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease-associated PINK1 G309D mutation increases abnormal phosphorylation of Tau.
Ye M; Zhou D; Zhou Y; Sun C
IUBMB Life; 2015 Apr; 67(4):286-90. PubMed ID: 25899925
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3 beta and tau genes interact in Parkinson's and Alzheimer's diseases.
García-Gorostiaga I; Sánchez-Juan P; Mateo I; Rodríguez-Rodríguez E; Sánchez-Quintana C; del Olmo SC; Vázquez-Higuera JL; Berciano J; Combarros O; Infante J
Ann Neurol; 2009 Jun; 65(6):759-61; author reply 761-2. PubMed ID: 19557862
[No Abstract] [Full Text] [Related]
13. The association between glycogen synthase kinase 3 beta polymorphisms and Parkinson's disease susceptibility: a meta-analysis.
Yuan Y; Tong Q; Zhou X; Zhang R; Qi Z; Zhang K
Gene; 2013 Jul; 524(2):133-8. PubMed ID: 23628795
[TBL] [Abstract][Full Text] [Related]
14. Association of GSK3B with Alzheimer disease and frontotemporal dementia.
Schaffer BA; Bertram L; Miller BL; Mullin K; Weintraub S; Johnson N; Bigio EH; Mesulam M; Wiedau-Pazos M; Jackson GR; Cummings JL; Cantor RM; Levey AI; Tanzi RE; Geschwind DH
Arch Neurol; 2008 Oct; 65(10):1368-74. PubMed ID: 18852354
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3β) on the risk of Parkinson's disease.
Infante J; García-Gorostiaga I; Sánchez-Juan P; Sierra M; Martín-Gurpegui JL; Terrazas J; Mateo I; Rodríguez-Rodríguez E; Berciano J; Combarros O
Eur J Neurol; 2010 May; 17(5):760-2. PubMed ID: 20039940
[TBL] [Abstract][Full Text] [Related]
16. GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals.
Dobson-Stone C; Polly P; Korgaonkar MS; Williams LM; Gordon E; Schofield PR; Mather K; Armstrong NJ; Wen W; Sachdev PS; Kwok JB
PLoS One; 2013; 8(8):e71750. PubMed ID: 23951236
[TBL] [Abstract][Full Text] [Related]
17. Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β.
Kawakami F; Shimada N; Ohta E; Kagiya G; Kawashima R; Maekawa T; Maruyama H; Ichikawa T
FEBS J; 2014 Jan; 281(1):3-13. PubMed ID: 24165324
[TBL] [Abstract][Full Text] [Related]
18. Correlation of tau gene polymorphism with age at onset of Parkinson's disease.
Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
Neurosci Lett; 2006 Sep; 405(3):202-6. PubMed ID: 16876320
[TBL] [Abstract][Full Text] [Related]
19. The tau gene haplotype h1 confers a susceptibility to Parkinson's disease.
Zhang J; Song Y; Chen H; Fan D
Eur Neurol; 2005; 53(1):15-21. PubMed ID: 15627775
[TBL] [Abstract][Full Text] [Related]
20. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease.
Winkler S; König IR; Lohmann-Hedrich K; Vieregge P; Kostic V; Klein C
Eur J Hum Genet; 2007 Nov; 15(11):1163-8. PubMed ID: 17637803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
